Article
Pancreatic cancer surveillance in a high-risk cohort. Is it worth the cost?
The Medical clinics of North America - 1 May 2000
Martin S P, Ulrich C D
Abstract excerpt
Pancreatic adenocarcinoma is the 10th most common malignancy and 4th largest cancer killer in adults. Earlier tumor detection through screening of high risk groups, presumably to increase the percentage of cases resectable for cure in these cohorts, has emerged as a prominent strategy to combat this disease. This article examines the feasibility of this strategy in patients with hereditary pancreatic cancer (HPC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
